- Home
- VCIG vs CLRB Comparison
VCIG vs CLRB Comparison
Compare VCIG & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCIG | CLRB |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 12.9M |
| IPO Year | 2022 | 2008 |
Fundamental Metrics
Financial Performance| Metric | VCIG | CLRB |
|---|---|---|
| Price | $1.48 | $2.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 828.2K | 46.4K |
| Earning Date | 05-08-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.23 |
| 52 Week High | $23.40 | $10.19 |
Technical Indicators
Market Signals| Indicator | VCIG | CLRB |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 37.29 |
| Support Level | $0.75 | $2.62 |
| Resistance Level | $2.18 | $3.56 |
| Average True Range (ATR) | 0.27 | 0.24 |
| MACD | -0.22 | -0.03 |
| Stochastic Oscillator | 3.65 | 0.00 |
Price Performance
Historical ComparisonAbout VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.